学术动态

　　SCI二区期刊医药方面期刊有哪些呢？SCI论文是很多作者梦寐以求的，想要提升国际影响力SCI论文是比较好的选择。SCI在国际上的影响力比较高，分区不同的期刊学术水平也是不同的。SCI二区期刊仅次于一区刊物，接下来，详细的推荐三本SCI二区医学刊物，仅供参考。

　　1、EUROPACE

　　学科领域：

　　大类：医学

　　小类：心脏和心血管系统

　　中科院分区：2区

　　期刊简介：EP - Europace - European Journal of Pacing, Arrhythmias and Cardiac Electrophysiology of the European Heart Rhythm Association of the European Society of Cardiology. The journal aims to provide an avenue of communication of top quality European and international original scientific work and reviews in the fields of Arrhythmias, Pacing and Cellular Electrophysiology. The Journal offers the reader a collection of contemporary original peer-reviewed papers, invited papers and editorial comments together with book reviews and correspondence.

　　2、APPETITE

　　学科领域：

　　大类：医学

　　小类：行为科学

　　中科院分区：2区

　　期刊简介：Appetite is an international research journal specializing in cultural, social, psychological, sensory and physiological influences on the selection and intake of foods and drinks.It covers normal and disordered eating and drinking and welcomes studies of both human and non-human animal behaviour toward food. Appetite publishes research reports, reviews and commentaries.

　　3、CNS DRUGS

　　学科领域：

　　大类：医学

　　小类：药学

　　中科院分区：2区

　　期刊简介：CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes:

　　- Overviews of contentious or emerging issues.

　　- Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses.

　　- Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.

　　- Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry.

　　- Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.